These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9308231)

  • 1. Receptor-specific regulation of NF-kappa B, c-Myc and Fas-mediated apoptosis in primary B cells.
    Francis DA; Sen R; Rothstein TL
    Curr Top Microbiol Immunol; 1997; 224():83-90. PubMed ID: 9308231
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
    Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
    J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
    Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
    Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
    EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction pathways that regulate the fate of B lymphocytes.
    Craxton A; Otipoby KL; Jiang A; Clark EA
    Adv Immunol; 1999; 73():79-152. PubMed ID: 10399006
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y; Hostager BS; Bishop GA
    J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
    Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A
    J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappa B is required for surface Ig-induced Fas resistance in B cells.
    Schram BR; Rothstein TL
    J Immunol; 2003 Mar; 170(6):3118-24. PubMed ID: 12626568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Rel/NF-kappaB transcription factors in B lymphocyte survival.
    Gerondakis S; Strasser A
    Semin Immunol; 2003 Jun; 15(3):159-66. PubMed ID: 14563114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-specific induction of NF-kappaB components in primary B cells.
    Francis DA; Sen R; Rice N; Rothstein TL
    Int Immunol; 1998 Mar; 10(3):285-93. PubMed ID: 9576616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.
    Smulski CR; Decossas M; Chekkat N; Beyrath J; Willen L; Guichard G; Lorenzetti R; Rizzi M; Eibel H; Schneider P; Fournel S
    Cell Death Dis; 2017 Feb; 8(2):e2601. PubMed ID: 28182009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
    Lee HH; Dadgostar H; Cheng Q; Shu J; Cheng G
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9136-41. PubMed ID: 10430908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.
    David A; Arnaud N; Fradet M; Lascaux H; Ouk-Martin C; Gachard N; Zimber-Strobl U; Feuillard J; Faumont N
    Haematologica; 2017 May; 102(5):883-894. PubMed ID: 28232371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-mediated apoptosis in murine B-lymphoma lines containing mutated p53.
    Hollmann AC; Gong Q; Owens T
    Exp Cell Res; 2002 Nov; 280(2):201-11. PubMed ID: 12413886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-dependent and Fas-independent mechanisms for selection of the mature human B cell repertoire.
    Defrance T; Billian G; Krammer PH; Lagresle C
    Ann N Y Acad Sci; 1997 Apr; 815():67-74. PubMed ID: 9186640
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).
    Donjerković D; Mueller CM; Scott DW
    Eur J Immunol; 2000 Apr; 30(4):1154-61. PubMed ID: 10760805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.